Daniele Santini

Pubblicazioni

Titolo Pubblicato in Anno
Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis (Targeted Oncology, (2020), 15, 4, (495-501), 10.1007/s11523-020-00732-y) TARGETED ONCOLOGY 2020
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report THE BREAST JOURNAL 2020
Regression of papillary thyroid cancer during nivolumab for renal cell cancer EUROPEAN THYROID JOURNAL 2020
Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report PRECISION CANCER MEDICINE 2020
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience JOURNAL OF CELLULAR PHYSIOLOGY 2019
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration‐resistant prostate cancer treated with 223Radium EUROPEAN JOURNAL OF CANCER CARE 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting INTERNATIONAL JOURNAL OF CANCER 2019
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab. a real-life multicentre study JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable JOURNAL FOR IMMUNOTHERAPY OF CANCER 2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice JOURNAL OF TRANSLATIONAL MEDICINE 2019
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy ANNALS OF ONCOLOGY 2019
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer LIVER INTERNATIONAL 2019
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study JOURNAL OF GERIATRIC ONCOLOGY 2019
Use of cardioprotective dexrazoxane and myelotoxicity in anthracycline-treated soft tissue sarcoma patients JOURNAL OF CLINICAL ONCOLOGY 2019
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Role of SIRT-3, p-mTOR and HIF-1 in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2019
A validated prognostic classifier for (V600E)BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study EUROPEAN JOURNAL OF CANCER 2019
The effect of a treatment delay on outcome in metastatic renal cell carcinoma UROLOGIC ONCOLOGY 2019
Early use of abiraterone and radium-223 in metastatic prostate cancer THE LANCET ONCOLOGY 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma